SymptomResponse
Patterns may reveal who’ll benefit from new schizophrenia drug
Patterns may reveal who’ll benefit from new schizophrenia drug A new study has identified patterns that may help predict which patients will benefit most from a new schizophrenia drug called Cobenfy. The study, led by Michael Halassa, analyzed data from 49 patients and found that those with prominent negative symptoms (such as social withdrawal) showed […]
🏥 Health